Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.8312 USD
−7.87 M USD
5.02 M USD
About GENETIC TECHNOLOGIES LIMITED
Sector
CEO
Simon Morriss
Website
Headquarters
Fitzroy
Founded
1987
FIGI
BBG000P9PKY3
Genetic Technologies Ltd. engages in the provision of molecular risk assessment tests for cancer. It operates through the following segments: EasyDNA, AffinityDNA, and GeneType/Corporate. The EasyDNA segment focuses on EasyDNA branded test sales and expenses. The AffinityDNA segment deals with AffinityDNA branded test sales and expenses. The GeneType/Corporate segment includes the GeneType branded test sales and expenses, including corporate charges. The company was founded on January 5, 1987, and is headquartered in Fitzroy, Australia.
Displays a symbol's price movements over previous years to identify recurring trends.